Previous studies show an opportunity for novel therapies for diabetes mellitus [12] and the relationship among FOXO1, gluconeogenesis, AMPK activation, PEPCK, G6Pase, and Akt [13,58,59,60,61]. This evidence concerns the gene PCK2 and diabetes mellitus.